The effect of rectal diclofenac on prevention of pancreatitis after ERCP

Phase 3

• Conditions: Acute pancreatitis.; K85; Acute panc

• Registration Number: IRCT20191231045969N2
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Age over 18 years
Ability to sign consent
Intact papilla
No contraindication for diclofenac
Having an ERCP indication

Exclusion Criteria

Acute pancreatitis
Allergy to diclofenac
Sphincterotomy
Basic amylase above 200

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acute pancreatitis after ERCP. Timepoint: 24 hours after ERCP operation. Method of measurement: Examination and testing of lipase amylase.